US$ 27.47
retatrutide safety retatrutide clinical trial FDA Approval Status 2026: Everything We Know So Far Retatrutide for weight loss: Study
Description
Can GLP-1 Medications Cause Emotional Side Effects

It is hypothesized that the slowing of gastric emptying contributes to some of the more common adverse events that occur with tirzepatide and selective GLP-1RAs (e.g., nausea, diarrhea, and vomiting), as the incidence of these events most commonly coincides with the timing of the early gastric slowing

Say you're gonna be on it for life

It often resolves with slower dose escalation or small meal adjustments
They mimic the hormone GLP-1 mentioned above
